Early Myocardial Dysfunction Helps Identify Severe Refractory Pediatric Lupus
Recruiting
Observational Study
Systemic Lupus Erythematosus (SLE)
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 7 – 17
- Sex
- Any
- Study type
- Observational
- Participants needed
- 60 (estimated)
- Sponsor
- Shanghai Jiao Tong University School of Medicine · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
To investigate biomarkers to identify pediatric SR-SLE patients by non-invasive echocardiographic techniques.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* fulfill the American College of Rheumatology (ACR) criteria
* disease onset at ages before 18 years
Exclusion Criteria:
* patients with a history of concomitant malignancy
* patients with active bacterial, viral, fungal, mycobacterial infection
Contacts
No contact information available.